Free Trial

Stevanato Group Q3 EPS Estimate Reduced by William Blair

Stevanato Group logo with Medical background

Key Points

  • William Blair has revised Stevanato Group's Q3 2025 earnings per share estimates down to $0.15, slightly below the previous estimate of $0.16, while maintaining an "Outperform" rating.
  • Stephens upgraded Stevanato Group to a "strong-buy" rating, contributing to an average rating of "Moderate Buy" and a consensus target price of €25.13 ($29.22).
  • The company has seen institutional investors increase their stakes, with Pembroke Management boosting its holdings by 24.8% in the second quarter.
  • Need better tools to track Stevanato Group? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Stevanato Group S.p.A. (NYSE:STVN - Free Report) - William Blair cut their Q3 2025 EPS estimates for shares of Stevanato Group in a research report issued on Wednesday, August 6th. William Blair analyst M. Larew now forecasts that the company will post earnings of $0.15 per share for the quarter, down from their previous estimate of $0.16. William Blair currently has a "Outperform" rating on the stock. The consensus estimate for Stevanato Group's current full-year earnings is $0.50 per share. William Blair also issued estimates for Stevanato Group's Q4 2025 earnings at $0.22 EPS, Q1 2026 earnings at $0.13 EPS and Q2 2026 earnings at $0.16 EPS.

Separately, Stephens upgraded shares of Stevanato Group to a "strong-buy" rating in a research report on Monday, April 21st. Two analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Stevanato Group currently has a consensus rating of "Moderate Buy" and an average target price of €25.13 ($29.22).

Check Out Our Latest Analysis on Stevanato Group

Stevanato Group Stock Performance

STVN stock traded down €0.24 ($0.28) on Friday, hitting €21.61 ($25.13). The company's stock had a trading volume of 232,464 shares, compared to its average volume of 340,587. The stock has a market cap of $6.54 billion, a price-to-earnings ratio of 40.02, a price-to-earnings-growth ratio of 2.23 and a beta of 0.55. The company has a current ratio of 1.79, a quick ratio of 1.22 and a debt-to-equity ratio of 0.25. Stevanato Group has a 1 year low of €17.12 ($19.91) and a 1 year high of €28.00 ($32.56). The firm has a 50 day moving average of €24.52 and a two-hundred day moving average of €22.45.

Hedge Funds Weigh In On Stevanato Group

Large investors have recently bought and sold shares of the company. Whittier Trust Co. acquired a new position in shares of Stevanato Group during the 1st quarter worth $27,000. Twin Tree Management LP acquired a new position in shares of Stevanato Group during the 1st quarter worth $29,000. Johnson Financial Group Inc. acquired a new position in shares of Stevanato Group during the 4th quarter worth $41,000. SVB Wealth LLC acquired a new position in shares of Stevanato Group during the 1st quarter worth $46,000. Finally, Van Berkom & Associates Inc. grew its stake in shares of Stevanato Group by 33.3% during the 1st quarter. Van Berkom & Associates Inc. now owns 2,400 shares of the company's stock worth $49,000 after purchasing an additional 600 shares during the period.

About Stevanato Group

(Get Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Read More

Earnings History and Estimates for Stevanato Group (NYSE:STVN)

Should You Invest $1,000 in Stevanato Group Right Now?

Before you consider Stevanato Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.

While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines